Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 ICON Launches Coronavirus Observatory | Contract Pharma
Breaking News

ICON Launches Coronavirus Observatory

Provides real-time updates on COVID-19 vaccine trials and insights into key issues.

ICON plc has launched the Coronavirus Observatory, a tool providing real-time updates on COVID-19 vaccine trials, and insights into key issues. The Coronavirus Observatory applies AI analysis and data visualization to COVID-19 news and also breaks down the global impact of the virus, looking at trending topics per country, and highlighting perspectives from key organizations.

“ICON is deeply committed to driving research into the Coronavirus and we are working tirelessly with our customers to develop a vaccine, therapeutics and testing kits, said, Nuala Murphy, President, Clinical Research Services, ICON plc. “But we have not forgotten the thousands of patients who rely on ICON and our customers to develop life-saving medications for a wide variety of other conditions. Our investigators are continuing this work despite the challenges of COVID-19 and we are using all the tools at our disposal to minimize disruption.”

In February, ICON mobilized its vaccine resources to address the COVID-19 global threat, including its ability to conduct home-based trials to minimize infection. The company is currently providing clinical monitoring and safety oversight on a number of COVID-19 trials for both the private and government sectors. These include a prophylactic vaccine study in healthy participants, and a study investigating antiviral treatment for patients with confirmed Coronavirus infection.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters